| ²é¿´: 4902 | »Ø¸´: 20 | |||
[½»Á÷]
ÖØÒª·¢ÏÖ£¡µØ×ôÐÁÕòÍ´»úÖÆ½ÒÃØ!
|
|||
|
µØ×ôÐÁÓÚ1986ÄêÓÉÃÀ¹ú»ÝÊÏ£¨Wyeth-Ayerst£©¹«Ë¾£¨Ä¿Ç°µÄ»ÔÈðPfizer£©Ñз¢ÉÏÊÐÓÃÓÚÖÎÁÆÊÖÊõºóÌÛÍ´£¬2011ÄêÔÚÃÀ¹úÍ£Ö¹ÏúÊÛ¡£2009ÄêÔÚÖйúÉÏÊÐÒÔÀ´±»¹ã·ºÓ¦ÓÃÓÚÈ«ÂéÓÕµ¼¡¢ÊõºóÕòÍ´ºÍ³¬Ç°ÕòÍ´£¬²¢ÓÃÓÚÖÎÁÆÄÚÔàÌÛÍ´ºÍ°©Ö¢ÌÛÍ´¡£Æä2016ÄêÏúÊÛ¶î½ü40ÒÚÈËÃñ±Ò£¬Ô¼ÎªÖйúµ¥Æ·ÖÖÒ©ÎïÏúÊÛǰµÚ5λ£¬Õ¼¾ÝÖйú°¢Æ¬ÀàÕòÍ´Ò©Îï44%Êг¡£¬¶øÂð·È½öÕ¼2%¡£µØ×ôÐÁÕòÍ´»îÐÔÓëÂð·ÈÏ൱£¬µ«ÆäÈ´½ÏÉÙÓкôÎüÒÖÖÆ¡¢±ãÃØ¡¢ÕòÍ´ÄÍÊܺͳÉñ«µÈ²»Á¼·´Ó¦¡£³¤ÆÚÒÔÀ´£¬µØ×ôÐÁ±»ÈÏΪÊǰ¢Æ¬ÊÜÌå»ìºÏ¼¤¶¯-Þ׿¹¼Á£¬Í¨¹ý²¿·Ö¼¤¶¯£¯Þ׿¹¦Ì-°¢Æ¬ÊÜÌåÒÔ¼°Óë¦Ê-£¯¦Ä-°¢Æ¬ÊÜÌåÏ໥×÷Óý鵼ÆäÕòÍ´»îÐÔ¡£½üÈÕ£¬ÉϺ£½»Í¨´óѧKing¡¯s LabÍõÓÀÏé½ÌÊÚÍŶÓÔÚNature×Ó¿¯Scientific ReportsÉÏ·¢±íÁËÌâΪ¡®Dezocine exhibits antihypersensitivity activities in neuropathy through spinal ¦Ì-opioid receptor activation and norepinephrine reuptake inhibition¡¯µÄÂÛÎÄ£¨http://www.nature.com/articles/srep43137£©£¬Ê״βûÃ÷µØ×ôÐÁµÄÕòÍ´»îÐÔÊÇͨ¹ý¼¤¶¯¼¹Ëè¦Ì-°¢Æ¬ÊÜÌ壨MOR£©ºÍÒÖÖÆÈ¥¼×ÉöÉÏÏÙËØÖØÉãÈ¡£¨NRI£©£¬Óë¦Ê-£¯¦Ä-°¢Æ¬ÊÜÌåÎ޹أ¬ÒàÓë5-ôÇÉ«°·ÖØÉãÈ¡Î޹ء£ ¸ÃÑо¿Òý·¢Á½µã˼¿¼£º1£©µØ×ôÐÁ×÷ΪµÚÒ»¸öMOR-NRI£¨first in class£©ÕòÍ´Ò©ÎïÒѱ»Ê¹ÓÃ27ÄêÖ®¾Ã£¬ÆäÎÊÊÀÏà½ÏÓÚ2009ÄêÓÉJohnson & Johnson Ñз¢ÉÏÊеı»¹«ÈÏΪÊǵÚÒ»¸öMOR-NRIÕòÍ´Ò©ÎïµÄËûÅçËû¶àÔçÁË23Ä꣬ÆäÔÚÃÀ¹úÏÂÊоßÌåÔÒòδ֪£¬µ«ÆäÔÚÖйúÌÛÍ´Êг¡ÖÐÈ¡´úÁËÂð·È±»¹ã·ºÓ¦Óã¬ÖйúÌÛÍ´Ò©ÎïʹÓÃÊг¡Ö¤Ã÷¸ÃÒ©ÓÅÓÚÂð·ÈµÄ²»Á¼·´Ó¦´ó´ó»ººÍÁËÖ±½ÓʹÓÃÂð·È´øÀ´µÄÒ©ÎïÒÀÀµºÍ°¢Æ¬³Éñ«µÈÖØ´ó½¡¿µºÍÉç»áÎÊÌ⣻2£©¸ÃÑо¿ÌôÕ½²¢ÍÆ·´«Í³Ñ§Êõ¹Ûµã£¬Ê×´ÎϵͳµØ²ûÃ÷µØ×ôÐÁÕòÍ´×÷ÓûúÖÆ£¬ÊǸÃÒ©Àú³ÌµÄÖØÒªÆªÕ¡£ |
» ±¾Ìû¸½¼þ×ÊÔ´Áбí
-
»¶Ó¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com - ¸½¼þ 1 : Dezocine_exhibits_antihypersensitivity_activities_in_neuropathy_through_spinal_¦Ì-opioid_receptor_activation_and_norepinephrine_reuptake_inhibition.pdf
2017-03-05 14:51:34, 1.79 M
» ²ÂÄãϲ»¶
2026Éê²©ÍÆ¼ö
ÒѾÓÐ1È˻ظ´
һƪÀ©É¢Ä£Ð͵ÄNature Machine IntelligenceÂÛÎĺÍElsevierÉϵÄÉî¶ÈѧϰҩÎïÊé¼®
ÒѾÓÐ1È˻ظ´
Ò©ÀíѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ159È˻ظ´
ÖйúÒ©¿Æ´óѧ2026Èëѧ²©Ê¿£¬Ò©ÎïºÏ³ÉºÍÉè¼Æ¾Ñ飬·ÅÉ仯ѧ¼°·ÅÉäҽѧÑо¿
ÒѾÓÐ25È˻ظ´
ʹÓÃMolAICal½øÐжàëÄÐéÄâɸѡ½Ì³Ì-ͬÑùÊÊÓÃÓÚµ°°×ÖʺͺËËáµÄÐéÄâɸѡ
ÒѾÓÐ1È˻ظ´
ʹÓÃMolAICal¼ÆËãÒ©Îﻯѧ¹ýÂËÆ÷MCFs¼°MCE-18ÃèÊö·û
ÒѾÓÐ0È˻ظ´
ʹÓÃMolAICal·¢ÏÖµ°°×ÊÜÌåDZÔڵĻîÐÔ¿Ú´ü¼°Î»µã
ÒѾÓÐ0È˻ظ´
»ªÀíҩѧѧ˶Çóµ÷¼Á£¬×Ü·Ö324
ÒѾÓÐ0È˻ظ´
292ҩѧµ÷¼Á
ÒѾÓÐ1È˻ظ´
°ÄÃÅÀí¹¤´óѧÈ˹¤ÖÇÄÜÒ©Îï·¢ÏÖÖÐÐÄÕÐÊÕ2026¼¶²©Ê¿Ñо¿Éú£¨ÉêÇë-¿¼ºËÖÆ£©
ÒѾÓÐ10È˻ظ´
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
¸£½¨Å©ÁÖ´óѧ²ÄÁϹ¤³ÌѧԺ¸ß·Ö×Ó²ÄÁÏ¿ÎÌâ×éÕÐÉú
+1/85
˫һÁ÷ÄϾ©Ò½¿Æ´óѧÕмÆËã»ú¡¢AI¡¢Í³¼Æ¡¢ÉúÎïÐÅÏ¢µÈ·½Ïò26Äê9ÔÂÈëѧ²©Ê¿
+1/84
Õã½Å©ÁÖ´óѧÕÐÊÕµ÷¼Á
+1/79
ÕÐÊÕ2026Äê²ÄÁÏÓ뻯¹¤×¨Ë¶µ÷¼Á£¬È«¹úÖØµãʵÑéÊÒ£¬¹ý¹ú¼ÒÏß¼´¿Éµ÷¼Á£¬Ãû¶î³ä×ã
+2/60
»¶Ó½»Á÷×Éѯ
+1/47
0854µç×ÓÐÅÏ¢µ÷¼Á£¬ÃöÄÏʦ´ó¹âµçоƬÑз¢ÊµÑéÊÒ£¬¿ÂÉÙÓ±½ÌÊÚ¿ÎÌâ×飬¼¯³Éµç·
+1/36
0854µç×ÓÐÅÏ¢µ÷¼Á£¬ÃöÄÏʦ´ó¹âµçоƬÑз¢ÊµÑéÊÒ
+1/35
´Óר¿ÆÒ»Â·µ½211˶ʿ£¬µ½TOP5²©Ê¿£¬Ò²Ïë½ø¸ßУÌåÖÆ
+1/33
---´óÁäµÄδ»éÄÐÕÒ½á»éÅ®¶ÔÏó
+1/19
ÕÐÊÕרҵ´úÂë08µÄѧ˶£¡
+1/16
ÖйúÅ©¿ÆÔºÀ¼ÖÝÄÁÒ©ËùÊÞÒ©´´ÐÂÓëÄÍÒ©ÐÔ¿ÆÑÐÍŶӯ¸¿ÆÑÐÖúÀí£¬¼±¼±¼±£¡
+1/15
ÖйúÖÐÒ½¿ÆÑ§ÔºÖÐÒ½Ò©½¡¿µ²úÒµÑо¿Ëù£¨½Î÷ÖÐÒ½Ò©½¡¿µ²úÒµÑо¿Ôº£©2026Äê¸ß²ã´ÎÈ˲ŵÈ
+1/12
¡¾²©Ê¿ÕÐÉú¡¿Î人¿Æ¼¼´óѧÕÐÊÕ²ÄÁÏ¡¢»¯¹¤¡¢»·¾³¡¢Ò±½ðÀà2026Äê¡°ÉêÇë-¿¼ºË¡±ÖƲ©Ê¿Éú
+1/7
Ïã¸Û´óѧDavid Srolovitz½ÌÊÚ¿ÎÌâ×éÕÐÆ¸¡¸Ïã½Ñ§Õß¡¹²©Ê¿ºó
+1/6
26ÄêÉ격×Ô¼ö-¼ÆËã»úÊÓ¾õ
+1/6
»ªÖпƼ¼´óѧ¹ÜÀíѧԺÕÐÆ¸Éç»áÓù¤£¨¿ÆÑÐÖúÀí£©1Ãû
+1/5
Ò׶ȲãÁ÷ÖÊÁ¿Á÷Á¿¿ØÖÆÆ÷ÔÚÍп¨Âí¿ËºË¾Û±ä×°ÖÃÖеÄÓ¦Óð¸ÀýÓëºËÐÄÓÅÊÆ
+1/5
¶«±±ÁÖÒµ´óѧ£¨211£¬Ë«Ò»Á÷£©ËÎÀÏʦ¿ÎÌâ×éÕÐÊո߷Ö×Ó¡¢»¯Ñ§¡¢¸´ºÏ²ÄÁϵȷ½ÏòÑо¿Éú
+1/4
125603¹¤Òµ¹¤³ÌÓë¹ÜÀíµ÷¼Á
+1/1
Î人ÇṤ´óѧÍÁľˮÀûÇཷ˶µ¼Õе÷¼Á
+1/1
2Â¥2017-03-05 14:54:25
| ÖØÒª·¢ÏÖ£¡£¡£¡µØ×ôÐÁÕòÍ´»úÖÆ½ÒÃØ£¨¼¤¶¯¦Ì-°¢Æ¬ÊÜÌ士ÒÖÖÆÈ¥¼×ÉöÉÏÏÙËØÖØÉãÈ¡£¬ºÍ¦ÊÊÜÌåÎ޹أ© |
4Â¥2017-03-05 15:05:05
¡ï
gn912(½ð±Ò+1): лл²ÎÓë
gn912(½ð±Ò+1): лл²ÎÓë
| Yong-Xiang Wang½ÌÊÚµÄÎÄÕÂȷʵºÜÓÐÒâÒ壬Ëü½ÒʾÁ˵Ø×ôÐÁÔÚ¼¹ËèˮƽµÄÕòʹлúÖÆ¡£µ«ÊÇÎÒÈÏΪ¥Ö÷µÄ×ܽáÉÔÓÐЩ¹ýÁË£¬ÎÒ²¢²»ÈÏΪÕâÊÇÍÆ·´«Í³¹ÛµãµÄÐÂÆªÕ£¬ÕâÆªÎÄÕÂÑо¿¾ÖÏÞÓÚ¼¹ËèˮƽµÄ»úÖÆ£¬²»ÄÜÀ©´óµ½ÍÆ·ÖÐÊàˮƽµÄ»úÖÆ£¬Ö»ÄÜ˵ÊÇÔÚ¼¹ËèˮƽµÄÕòʹй۵㡣¶øÇÒGharagozlou PºÍLiu RµÈÍŶӾù֤ʵµØ×ôÐÁÊÇKOR antagonist£¬Yu-Hua WangµÄÑо¿ÈÏΪµØ×ôÐÁµÄKOR¼¤¶¯Ð§ÄÜÒ²½öΪKORÍêÈ«¼¤¶¯¼ÁµÄ33.6%¶øÒÑ£¬ÓëYong-Xiang Wang½ÌÊÚµÄÎÄÕ²¢ÎÞ³åÍ»£¬ºÎÀ´ÍƷ֮˵£¿Â¥Ö÷µÄÆÀ¼Û¹ý¼¤ÁË¡£ |
» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©
14Â¥2018-10-25 14:35:15
5Â¥2017-03-06 16:29:51
7Â¥2017-03-24 11:53:13
9Â¥2017-11-02 10:43:33
belladonae
½ð³æ (ÖøÃûдÊÖ)
- DRDEPI: 1
- Ó¦Öú: 189 (¸ßÖÐÉú)
- ½ð±Ò: 4720
- Ìû×Ó: 2155
- ÔÚÏß: 1390.6Сʱ
- ³æºÅ: 467524
10Â¥2017-11-07 16:28:58
11Â¥2017-11-08 07:35:16
12Â¥2017-11-08 07:36:01
13Â¥2018-04-08 13:49:56
15Â¥2019-05-26 00:16:30
¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
|
ÓиöÎÊÌâÎÒÈÌÁ˺ܾÃÁË£¬ÊµÔÚÈ̲»×¡ÎÊÁË¡£ÎªÊ²Ã´Õâ¸öÌû×Ó17ÄêµÄ£¬Ã¿´Î¶¼»¹ÏÔʾÔÚÎÒµÄÒ³ÃæµÄ×îÉÏÃæÄØ£¿ºÃÆæ ·¢×ÔСľ³æAndroid¿Í»§¶Ë |
17Â¥2020-06-02 21:27:54
gwmgyp
°æÖ÷ (ÖªÃû×÷¼Ò)
- DRDEPI: 8
- Ó¦Öú: 820 (²©ºó)
- ¹ó±ö: 3.006
- ½ð±Ò: 17161.9
- Ìû×Ó: 5612
- ÔÚÏß: 944.5Сʱ
- ³æºÅ: 1272275
19Â¥2020-06-03 13:20:16
20Â¥2020-06-03 21:09:31
̸ÅÐÌÕ
ÈÙÓþ°æÖ÷ (ÎÄ̳¾«Ó¢)
- Ó¦Öú: 157 (¸ßÖÐÉú)
- ¹ó±ö: 6.405
- ½ð±Ò: 206511
- Ìû×Ó: 16796
- ÔÚÏß: 3831.9Сʱ
- ³æºÅ: 1272330
21Â¥2020-08-07 20:29:39
¼òµ¥»Ø¸´
dsctg3Â¥
2017-03-05 14:57
»Ø¸´
gn912(½ð±Ò+1): лл²ÎÓë
wdxmu6Â¥
2017-03-06 20:30
»Ø¸´
½ð¸ÕÀÇ1218Â¥
2017-07-26 16:12
»Ø¸´
gn912(½ð±Ò+1): лл²ÎÓë


ÆßҶƯƯ16Â¥
2019-06-28 11:45
»Ø¸´
gn912(½ð±Ò+1): лл²ÎÓë
£¬ ·¢×ÔСľ³æAndroid¿Í»§¶Ë
gwmgyp18Â¥
2020-06-03 13:18
»Ø¸´














»Ø¸´´ËÂ¥
̸ÅÐÌÕ